|
Predictors
|
Stratification factors
| |
β
|
95% CI
|
P value
|
|---|
|
Preoperative levodopa responsiveness
|
Gender
|
Female
|
1.1a
|
(0.3,1.9)
|
0.0294*
|
|
Male
|
0.6a
|
(−0.4,1.6)
|
0.2901
|
|
Disease duration, y
|
<10
|
2.0a
|
(1.1,2.9)
|
0.0021**
|
|
> = 10
|
−0.1a
|
(−0.9,0.8)
|
0.8874
|
|
Motor fluctuations duration, y
|
<=3
|
3.1a
|
(0.8,5.5)
|
0.0393*
|
|
>3
|
0.5a
|
(−0.4,1.3)
|
0.3061
|
|
Disease subtype(PIGD/LPS)
|
Motor fluctuations duration, y
|
>3
|
−38.4b
|
(−67.1,−9.7)
|
0.039*
|
|
Disease severity
|
>50
|
−41.1b
|
(−61.8,−20.4)
|
0.03*
|
-
arefers to the value of β means that as each increase of 1% of Levodopa responsiveness, the postoperative motor function improved as a certain amplitude; brefers to the value of β means the difference of motor improvement of PIGD group compared to that of LPS group; **p < 0.01, *p < 0.05; Disease severity was measured by the baseline UPDRS scores of part III
